Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

lidocaine mixture with tribenoside

A formulation composed of the local anesthetic lidocaine and the vasoprotective agent tribenoside that can be used for the treatment of hemorrhoids. Upon rectal administration of the lidocaine mixture with tribenoside, lidocaine stabilizes the neuronal membrane by binding to and inhibiting voltage-gated sodium channels, thereby inhibiting the ionic fluxes required for the initiation and conduction of impulses. This causes local anesthesia and relieves pain. Tribenoside may exert anti-inflammatory, mild analgesic, wound-healing, fibrinolysis-promoting, membrane-stabilizing and venotropic properties. This may relieve pain, halt inflammation, protect blood vessels, and may help repair and heal wounds.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Procto-glyvenol
Chemical structure:D-glucofuranoside, ethyl 3,5,6-tris-O-(phenylmethyl)-, mixt. with 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search